Clinical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U01 Clinical Trial Optional) (PAR-24-097)

Sponsor: National Institute of Neurological Disorders and Stroke

Due Date: Multiple due dates; see announcement.

Analytical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U44 Clinical Trial Optional) (PAR-24-098)

Sponsor: National Institute of Neurological Disorders and Stroke

Award: Budgets up to $700,000 total costs per year for Phase I and up to $1,500,000 total costs per year for Phase II may be requested. The maximum project period is 4 years.

Due Date: Multiple due dates; see announcement.

Notice of Special Interest: Use of Digital Technology and mHealth `to Improve Diagnosis, Assessments, Interventions, Management and Outcomes for Individuals with Down Syndrome (R21) (NOT-OD-24-044)

Sponsor: National Institutes of Health

Cure PSP Student Fellowships

Sponsor: Cure PSP

Due Date: January 21, 2024

Notice of Intent to Publish an FOA for Open Measurement Coordinating Network for Non-Pharmacological AD and ADRD Primary Prevention Trials (U24 Clinical Trial Not Allowed) (NOT-AG-23-061)

Sponsor: National Institute on Aging

Due Date: Estimated Publication Date of Notice of Funding Opportunity: February 01, 2024. First Estimated Application Due Date: June 07, 2024.

NINDS Exploratory Clinical Trials for Small Business (R43/R44 Clinical Trial Required) (PAR-23-311)

Sponsor: National Institute of Neurological Disorders and Stroke

Due Date: Multiple due dates; see announcement.

NINDS Exploratory Clinical Trials for Small Business (R41/R42 Clinical Trial Required) (PAR-24-044)

Sponsor: National Institute of Neurological Disorders and Stroke

Due Date: Multiple due dates; see announcement.

Limited Competition: Small Grant Program for the NCATS Clinical and Translational Science Award (CTSA) Program (R03 Clinical Trial Optional) (PAR-24-042)

Sponsor: National Institutes of Health

Award: Application budgets are limited to direct costs up to $50,000 per year and need to reflect the actual needs of the proposed project. The maximum period of support is 2 years.

Due Date: Multiple due dates; see announcement.

Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional) (PAR-24-043)

Sponsor: National Institutes of Health

Due Date: Multiple due dates; see announcement.

Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional) (PAR-24-063)

Sponsor: National Institutes of Health

Due Date: Multiple due dates; see announcement.

Enhancing Biomedical Engineering, Imaging, and Technology Acceleration (BEITA) at Historically Black Colleges and Universities (HBCUs) (UG3/UH3 Clinical Trial Not Allowed) (RFA-EB-23-006)

Sponsor: National Institute of Biomedical Imaging and Bioengineering

Due Date: Multiple due dates; see announcement.

Unveiling Health and Healthcare Disparities in Non-Communicable and Chronic Diseases in Latin America: Setting the Stage for Better Health Outcomes Across the Hemisphere (R01) (PAR-23-303)

Sponsor: National Institutes of Health

Due Date: Multiple due dates; see announcement.

BRAIN Initiative: New Concepts and Early-Stage Research for Recording and Modulation in the Nervous System (R21) (Clinical Trial Not Allowed) (RFA-EY-23-001)

Sponsor: National Institutes of Health

Award: Application budgets may not exceed $400,000 total direct costs over a maximum three-year funding period. No more than $200,000 in direct costs may be requested in any single year.

Due Date: Multiple due dates; see announcement.

Request for Applications: Essential Open Source Software for Science

Sponsor: Chan Zuckerberg Initiative

Award: Applicants can request funding between $50K and $200K total costs per year for two years for a total amount between $100K and $400K total costs for the duration of the grant.

Due Date: October 17, 2023

Early-stage Biomedical Data Repositories and Knowledgebases (R24 Clinical Trial Not Allowed) (PAR-23-236)

Sponsor: National Institutes of Health

Due Date: Multiple due dates; see announcement.